The measurement of neurofilament light chain (NfL) in blood is a promising biomarker of neurological injury and disease. We investigated the genetic factors that underlie serum NfL levels (sNfL) of individuals without neurological conditions.
We performed a discovery genome-wide association study (GWAS) of sNfL in participants of the German BiDirect Study (
Our discovery GWAS identified 12 genomic loci at the suggestive threshold ((
Our findings suggest that polygenic regulation of neuronal processes, inflammation, metabolism and clearance modulate the variability of NfL in the circulation. These could aid in the interpretation of sNfL measurements in a personalized manner.